Inhibition of Mycoplasma pneumoniae by actinomycin D

Insights

Mycoplasma pneumoniae growth is highly sensitive to actinomycin D, with low concentrations inhibiting RNA synthesis and high concentrations affecting both RNA and DNA synthesis. This suggests M. pneumoniae is more susceptible to this antibiotic than previously understood.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Mycoplasma pneumoniae is a significant human pathogen.
  • Actinomycin D is an antibiotic known to inhibit nucleic acid synthesis.

Purpose of the Study:

  • To investigate the susceptibility of Mycoplasma pneumoniae to actinomycin D.
  • To determine the effects of different actinomycin D concentrations on M. pneumoniae nucleic acid synthesis.

Main Methods:

  • Exposure of M. pneumoniae cultures to varying concentrations of actinomycin D.
  • Quantification of M. pneumoniae growth inhibition.
  • Measurement of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) synthesis.

Main Results:

  • Complete growth inhibition of M. pneumoniae occurred at 0.06 µg/ml of actinomycin D.
  • 90% growth inhibition was observed at 0.00375 µg/ml of actinomycin D.
  • Low actinomycin D concentrations (0.019 µg/ml) primarily inhibited RNA synthesis, while high concentrations (20 µg/ml) inhibited both RNA and DNA synthesis.

Conclusions:

  • Mycoplasma pneumoniae exhibits greater susceptibility to actinomycin D than previously reported.
  • Actinomycin D's mechanism of action on M. pneumoniae involves inhibition of nucleic acid synthesis, with concentration-dependent effects on RNA and DNA.

Related Concept Videos

Bacterial Phylum Actinobacteria01:30

Bacterial Phylum Actinobacteria

Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...